top

  Info

  • Utilizzare la checkbox di selezione a fianco di ciascun documento per attivare le funzionalità di stampa, invio email, download nei formati disponibili del (i) record.

  Info

  • Utilizzare questo link per rimuovere la selezione effettuata.
Guidelines for the programmatic management of drug-resistant tuberculosis [[electronic resource] ] : emergency update 2008
Guidelines for the programmatic management of drug-resistant tuberculosis [[electronic resource] ] : emergency update 2008
Edizione [Emergency update.]
Pubbl/distr/stampa Geneva, : World Health Organization, Stop TB Department, c2008
Descrizione fisica 1 online resource (270 p.)
Disciplina 615.58
Altri autori (Persone) JaramilloErnesto
Soggetto topico Antitubercular agents
Comorbidity - Treatment
Highly active antiretroviral therapy
HIV infections - Chemotherapy
Multidrug-resistant tuberculosis - Chemotherapy
Multidrug-resistant tuberculosis - Prevention
ISBN 1-282-05799-5
9786612057991
92-4-068353-4
Formato Materiale a stampa
Livello bibliografico Monografia
Lingua di pubblicazione eng
Nota di contenuto COVER; COPYRIGHT; CONTENTS; Acknowledgements; Abbreviations; Executive summary; Foreword to the 2008 emergency updated edition; CHAPTER 1: Background information on DR-TB; CHAPTER 2: Framework for effective control of DR-TB; CHAPTER 3: Political commitment and coordination; CHAPTER 4: Definitions:case registration, bacteriology and treatment outcomes; CHAPTER 5: Case-finding strategies; CHAPTER 6: Laboratory aspects; CHAPTER 7: Treatment strategies for MDR-TB and XDR-TB; CHAPTER 8: Mono-resistant and poly-resistant strains; CHAPTER 9: Treatment of DR-TB in special conditions and situations
CHAPTER 10: DR-TB and HIV infectionCHAPTER 11: Initial evaluation, monitoring of treatment and management of adverse effects; CHAPTER 12: Treatment delivery and community-based DR-TB support; Chapter 13: Management of patients after MDR-TB treatment failure; CHAPTER 14: Management of contacts of MDR-TB patients; CHAPTER 15: Drug resistance and infection control; CHAPTER 16: Human resources:training and staffing; CHAPTER 17: Management of second-line antituberculosis drugs; CHAPTER 18: Category IV recording and reporting system; CHAPTER 19: Managing DR-TB through patient-centred care
ANNEX 1: Drug information sheetsANNEX 2: Weight-based dosing of drugs for adults; ANNEX 3: Suggestions for further reading; ANNEX 4: Legislation, human rights and patients' rights in tuberculosis prevention and control; ANNEX 5: Use of experimental drugs outside of clinical trials ("compassionate use"); ANNEX 6: Methodology; FORMS; INDEX; BACK COVER
Record Nr. UNISA-996320228203316
Geneva, : World Health Organization, Stop TB Department, c2008
Materiale a stampa
Lo trovi qui: Univ. di Salerno
Opac: Controlla la disponibilità qui
Guidelines for the programmatic management of drug-resistant tuberculosis : emergency update 2008
Guidelines for the programmatic management of drug-resistant tuberculosis : emergency update 2008
Edizione [Emergency update.]
Pubbl/distr/stampa Geneva, : World Health Organization, Stop TB Department, c2008
Descrizione fisica 1 online resource (270 p.)
Disciplina 615.58
Soggetto topico Antitubercular agents
Comorbidity - Treatment
Highly active antiretroviral therapy
HIV infections - Chemotherapy
Multidrug-resistant tuberculosis - Chemotherapy
Multidrug-resistant tuberculosis - Prevention
ISBN 1-282-05799-5
9786612057991
92-4-068353-4
Formato Materiale a stampa
Livello bibliografico Monografia
Lingua di pubblicazione eng
Nota di contenuto COVER; COPYRIGHT; CONTENTS; Acknowledgements; Abbreviations; Executive summary; Foreword to the 2008 emergency updated edition; CHAPTER 1: Background information on DR-TB; CHAPTER 2: Framework for effective control of DR-TB; CHAPTER 3: Political commitment and coordination; CHAPTER 4: Definitions:case registration, bacteriology and treatment outcomes; CHAPTER 5: Case-finding strategies; CHAPTER 6: Laboratory aspects; CHAPTER 7: Treatment strategies for MDR-TB and XDR-TB; CHAPTER 8: Mono-resistant and poly-resistant strains; CHAPTER 9: Treatment of DR-TB in special conditions and situations
CHAPTER 10: DR-TB and HIV infectionCHAPTER 11: Initial evaluation, monitoring of treatment and management of adverse effects; CHAPTER 12: Treatment delivery and community-based DR-TB support; Chapter 13: Management of patients after MDR-TB treatment failure; CHAPTER 14: Management of contacts of MDR-TB patients; CHAPTER 15: Drug resistance and infection control; CHAPTER 16: Human resources:training and staffing; CHAPTER 17: Management of second-line antituberculosis drugs; CHAPTER 18: Category IV recording and reporting system; CHAPTER 19: Managing DR-TB through patient-centred care
ANNEX 1: Drug information sheetsANNEX 2: Weight-based dosing of drugs for adults; ANNEX 3: Suggestions for further reading; ANNEX 4: Legislation, human rights and patients' rights in tuberculosis prevention and control; ANNEX 5: Use of experimental drugs outside of clinical trials ("compassionate use"); ANNEX 6: Methodology; FORMS; INDEX; BACK COVER
Record Nr. UNINA-9910145965203321
Geneva, : World Health Organization, Stop TB Department, c2008
Materiale a stampa
Lo trovi qui: Univ. Federico II
Opac: Controlla la disponibilità qui